Trademark Overview
On Friday, February 7, 2025, a trademark application was filed for SUPER-ADCS with the United States Patent and Trademark Office. The USPTO has given the SUPER-ADCS trademark a serial number of 99033250. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 7, 2025. This trademark is owned by BioLoomics, Inc. The SUPER-ADCS trademark is filed in the Chemical Products category with the following description:
Biochemicals, namely, antibody drug conjugates combining antibodies with chemotherapeutic payloads for in vitro and in vivo scientific and research purposes, as well as clinical therapeutic purposes; Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Reagents for scientific or medical research use; A compound combining engineered protein with one or many chemotherapeutics in raw material form for scientific and medical research, as well as clinical therapeutic use
